(Tirzepatide) for Type 2 Diabetes and Weight Management

What Is  (Tirzepatide) Injection for Type 2 Diabetes?

Mounjaro is a once-weekly GIP and GLP-1 receptor agonist injection prescribed to improve blood sugar control in adults with type 2 diabetes.

How it Works as a Dual GIP and GLP-1 Receptor Agonist

It (tirzepatide) activates both GIP and GLP-1 receptors to enhance insulin secretion, reduce glucagon levels, slow digestion, and regulate appetite.

It for Weight Loss and Blood Sugar Control

In addition to lowering HbA1c levels, Mounjaro supports significant weight reduction by decreasing appetite and improving metabolic function.

Benefits of Mounjaro Weekly Injection for Diabetes Treatment

• Once-weekly subcutaneous injection

• Improved glycemic control

• Clinically proven weight loss support

• Cardiometabolic health benefits

It Dosage, Weekly Pen Administration, and Treatment Plan

It is administered as a weekly injection using a prefilled pen. Dosage is gradually increased to reduce gastrointestinal side effects.

Possible Side Effects of  (Tirzepatide Therapy)

Common side effects include nausea, diarrhea, decreased appetite, and stomach discomfort. Medical supervision is required during treatment.